I Jiménez‐Nácher

487 total citations
12 papers, 371 citations indexed

About

I Jiménez‐Nácher is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, I Jiménez‐Nácher has authored 12 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Virology and 4 papers in Epidemiology. Recurrent topics in I Jiménez‐Nácher's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (4 papers) and Hepatitis C virus research (3 papers). I Jiménez‐Nácher is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (4 papers) and Hepatitis C virus research (3 papers). I Jiménez‐Nácher collaborates with scholars based in Spain. I Jiménez‐Nácher's co-authors include Vincent Soriano, Sonia Rodríguez‐Nóvoa, Pablo Barreiro, J. Gonzalez-Lahoz, Juan González‐Lahoz, Eulalia Valencia, Rafael Rodrı́guez-Rosado, Judit Morelló, Benito García and Carmen de Mendoza and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Hepatology and Clinical Chemistry.

In The Last Decade

I Jiménez‐Nácher

11 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Jiménez‐Nácher Spain 7 247 149 122 79 48 12 371
Rosa Ruiz-Valderas Spain 12 342 1.4× 160 1.1× 189 1.5× 46 0.6× 35 0.7× 26 457
L. Trentini Italy 11 257 1.0× 137 0.9× 78 0.6× 63 0.8× 47 1.0× 25 354
Amelia S. Petry United States 7 367 1.5× 209 1.4× 119 1.0× 64 0.8× 50 1.0× 9 423
Gema González‐Pardo Spain 7 348 1.4× 169 1.1× 128 1.0× 81 1.0× 112 2.3× 9 454
Gong Shen United States 11 349 1.4× 113 0.8× 167 1.4× 142 1.8× 30 0.6× 21 516
Tsunefusa Hayashida Japan 14 423 1.7× 277 1.9× 202 1.7× 77 1.0× 57 1.2× 31 655
Michelle Bentata France 10 308 1.2× 237 1.6× 170 1.4× 125 1.6× 121 2.5× 16 616
E M Cretton United States 10 242 1.0× 139 0.9× 94 0.8× 35 0.4× 18 0.4× 12 402
Marchina van der Ende Netherlands 8 286 1.2× 197 1.3× 73 0.6× 16 0.2× 53 1.1× 15 408
Clotilde Le Tiec France 8 330 1.3× 216 1.4× 78 0.6× 16 0.2× 66 1.4× 10 432

Countries citing papers authored by I Jiménez‐Nácher

Since Specialization
Citations

This map shows the geographic impact of I Jiménez‐Nácher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Jiménez‐Nácher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Jiménez‐Nácher more than expected).

Fields of papers citing papers by I Jiménez‐Nácher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Jiménez‐Nácher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Jiménez‐Nácher. The network helps show where I Jiménez‐Nácher may publish in the future.

Co-authorship network of co-authors of I Jiménez‐Nácher

This figure shows the co-authorship network connecting the top 25 collaborators of I Jiménez‐Nácher. A scholar is included among the top collaborators of I Jiménez‐Nácher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Jiménez‐Nácher. I Jiménez‐Nácher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Rodríguez‐Nóvoa, Sonia, et al.. (2010). Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701. Journal of Antimicrobial Chemotherapy. 65(8). 1567–1569. 29 indexed citations
3.
Medraño, J., Salvador Resino, Eugenia Vispo, et al.. (2010). Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV‐coinfected patients. Journal of Viral Hepatitis. 18(5). 325–330. 27 indexed citations
4.
Vispo, Eugenia, Ivana Maida, Francisco J. Blanco, et al.. (2010). 1160 HEPATIC SAFETY PROFILE OF NEW ANTIRETROVIRAL DRUGS IN HIV-INFECTED PATIENTS WITH CHRONIC HEPATITIS C. Journal of Hepatology. 52. S448–S448. 1 indexed citations
5.
Jiménez‐Nácher, I, Benito García, Pablo Barreiro, et al.. (2008). Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements. Journal of Antimicrobial Chemotherapy. 62(4). 816–822. 32 indexed citations
6.
Rodríguez‐Nóvoa, Sonia, Pablo Barreiro, I Jiménez‐Nácher, & Vincent Soriano. (2006). Overview of the pharmacogenetics of HIV therapy. The Pharmacogenomics Journal. 6(4). 234–245. 49 indexed citations
7.
Barreiro, Pablo, et al.. (2005). Nucleoside/nucleotide backbones for the treatment of HIV infection.. PubMed. 6(8). 812–22. 3 indexed citations
8.
Rodríguez‐Nóvoa, Sonia, et al.. (2005). Influence of 516G>T Polymorphisms at the Gene Encoding the CYP450-2B6 Isoenzyme on Efavirenz Plasma Concentrations in HIV-Infected Subjects. Clinical Infectious Diseases. 40(9). 1358–1361. 147 indexed citations
9.
Núñez, Marina, et al.. (2005). Clinical benefit of interventions driven by therapeutic drug monitoring. HIV Medicine. 6(5). 360–365. 24 indexed citations
10.
Rodrı́guez-Rosado, Rafael, I Jiménez‐Nácher, Eulalia Valencia, Vincent Soriano, & Juan González‐Lahoz. (1998). Nephrolithiasis in HIV-Infected Patients Treated with Indinavir. Antiviral Therapy. 3(2). 113–113. 55 indexed citations
11.
Jiménez‐Nácher, I, Benito García, & Vincent Soriano. (1998). [Drug interactions in patients infected with the human immunodeficiency virus].. PubMed. 198(11). 765–8. 1 indexed citations
12.
Portolés, Manuel, et al.. (1988). Neopterin, thyroxin, and human immunodeficiency virus antibodies in the newborn of opiate-addicted mothers.. Clinical Chemistry. 34(1). 180–180. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026